Study of advanced renal tumors

Prospective Study of Management and Outcomes of Metastatic Renal Tumors

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2016/09/007317

Enrollment

Registered

2016-09-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Metastatic RCC

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All cases of metastatic renal tumors presenting to department of urology, KGMU

Exclusion criteria

Exclusion criteria: Patients with other malignancies. Patients with primary focus of malignancy other than that of renal origin Patients unwilling for treatment.

Design outcomes

Primary

Measure	Time frame
To study the differences in clinical, pathological and radiological characteristics of metastatic renal tumors Timepoint: 24months	—

Secondary

Measure	Time frame
To evaluate the clinico-pathological outcomes while treating them on current recommended regimens Timepoint: 24months	—

Countries

India

Contacts

Public ContactMANAV AGARWAL

KGMU

drvishwajeet68@gmail.com7607683654

Outcome results